Jennifer J Turner

Jennifer J Turner

UNVERIFIED PROFILE

Are you Jennifer J Turner?   Register this Author

Register author
Jennifer J Turner

Jennifer J Turner

Publications by authors named "Jennifer J Turner"

Are you Jennifer J Turner?   Register this Author

29Publications

636Reads

28Profile Views

Patterns and trends in the incidence of paediatric and adult germ cell tumours in Australia, 1982-2011.

Cancer Epidemiol 2016 08 26;43:15-21. Epub 2016 May 26.

Centre for Big Data Research in Health, University of New South Wales, Sydney, NSW, 2052, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canep.2016.05.006DOI Listing
August 2016

Immunoglobulin Type Gamma 4-Related Disease Presenting with Cutaneous Plaques.

Australas J Dermatol 2016 Feb;57(1):74

Department of Dermatology, University of Tasmania, Launceston, Tasmania, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajd.12240DOI Listing
February 2016

Extraprostatic extension (EPE) of prostatic carcinoma: is its proximity to the surgical margin or Gleason score important?

BJU Int 2015 Sep 15;116(3):343-50. Epub 2014 Dec 15.

Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.12911DOI Listing
September 2015

Lymphoid neoplasm incidence by WHO subtype in Australia 1982-2006.

Int J Cancer 2014 Nov 2;135(9):2146-56. Epub 2014 Apr 2.

Adult Cancer Program, Lowy Cancer Research Centre, Prince of Wales Clinical School, The University of New South Wales, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.28849DOI Listing
November 2014

Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes Project.

J Natl Cancer Inst Monogr 2014 Aug;2014(48):1-14

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (LMM, JNS, SMM, JSC, SIB, MSL); Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN (JRC, DR, ADN, SLS); Department of Histopathology, Douglass Hanly Moir Pathology, Macquarie Park, Australia, The Australian School of Advanced Medicine, Macquarie University, Sydney, Australia (JJT); Prince of Wales Clinical School, University of New South Wales, Sydney, Australia (CMV); Department of Cancer Etiology, City of Hope Beckman Research Institute, Duarte, CA (SSW); Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden (KES); Unit of Infections and Cancer, Cancer Epidemiology Research Programme, Institut Catala d'Oncologia, IDIBELL, Barcelona, Spain, CIBER de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain (SdS, YB); Inserm, Centre for Research in Epidemiology and Population Health (CESP), Environmental Epidemiology of Cancer Group and Univ Paris Sud, Villejuif, France (AM, JC); Registry of Hematological Malignancies in Gironde, Bergonié Institute, Bordeaux, France (AM); Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA (PMB); Department of Health Studies, University of Chicago, Chicago, IL (BCHC); Department of Epidemiology, Comprehensive Cancer Center, University of Alabama, Birmingham, AL (CFS); Department of Environmental Health Sciences, Yale School of Public Health, New Haven, CT (YZ); Information Management Systems, Inc, Silver Spring, MD (MS); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, UK (EVK, ER); Cancer Control Research, BC Cancer Agency, Vancouver, BC, Canada (JJS); School of Medicine and Dentistry, University of Rochester, Rochester, NY (JLK); Department of Epidemiology, IRCCS - Istituto di Ricerche Farmacologiche Mario Negri and Department of Clinical Sciences and Community Hea

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jncimonographs/lgu005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155460PMC
August 2014

Medical history, lifestyle, family history, and occupational risk factors for marginal zone lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

J Natl Cancer Inst Monogr 2014 Aug;2014(48):52-65

Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA (PMB, EAH); Unit of Infections and Cancer (UNIC), Cancer Epidemiology Research Programme, Institut Catala d'Oncologia, IDIBELL, Barcelona, Spain, CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain (YB, SdS); Department of Histopathology, Douglass Hanly Moir Pathology, Sydney, Australia, The Australian School of Advanced Medicine, Macquarie University, Sydney, Australia (JJT); Department of Entomology, The Robert H. Smith Faculty of Agriculture, Koret School of Veterinary Medicine Veterinary Teaching Hospital, Hebrew University of Jerusalem, Rehovot, Israel (OP); Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN (SLS, ADN, JRC); Prince of Wales Clinical School, University of New South Wales, Sydney, Australia (CMV); Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany (NB); Department of Health Studies, University of Chicago, Chicago, IL (BCHC); Department of Public Health, Clinical and Molecular Medicine, Occupational Health Section, University of Cagliari, Cagliari, Italy (PC); Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY (AD); Center for Chronic Immunodeficiency (CCI), University Medical Center Freiburg, Freiburg, Germany (AN); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, Heslington, York, UK (EVK, ER); Unit of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden (KES); Biological Hematology Unit, CRB Ferdinand Cabanne, University Hospital of Dijon and University of Burgundy, Dijon, France (MM); Cancer Control Research, BC Cancer Agency, Vancouver, BC, Canada (JJS); Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden, Department of Oncology and Pathology, Karolinska Institutet, Stockhol

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jncimonographs/lgu011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207869PMC
August 2014

Medical history, lifestyle, family history, and occupational risk factors for mantle cell lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

J Natl Cancer Inst Monogr 2014 Aug;2014(48):76-86

Unit of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden (KES); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (JNS, SIB, LMM); Department of Histopathology, Douglass Hanly Moir Pathology, Macquarie Park, Australia The Australian, School of Advanced Medicine, Macquarie University, Sydney, Australia (JJT); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SLS, TMH); Biological Hematology Unit; CRB Ferdinand Cabanne, University Hospital of Dijon, Dijon, France, EA4184, University of Burgundy, Dijon, France (MM); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, UK (ER); Winship Cancer Institute, Emory University, Atlanta, GA (CRF); Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA (PMB); Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark (HH); Department of Pathology, City of Hope National Medical Center, Duarte, CA (DDW).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jncimonographs/lgu007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155462PMC
August 2014

Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

J Natl Cancer Inst Monogr 2014 Aug;2014(48):130-44

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (LMM, SMM, JSC, PH, NR, AB, KPC, QL, SIB, MSL, JNS); Department of Health Sciences Research (SLS, JRC, TMH), Division of Hematology (TGC), and Divison of General Internal Medicine (ML), College of Medicine, Mayo Clinic, Rochester, MN; Department of Cancer Etiology, City of Hope Beckman Research Institute, Duarte, CA (SSW, LB, AL); Prince of Wales Clinical School, University of New South Wales, Sydney, Australia (CMV); Department of Epidemiology, Comprehensive Cancer Center, University of Alabama, Birmingham, AL (CFS); Department of Epidemiology and Biostatistics, School of Medicine, University of California San Francisco, San Francisco, CA (PMB, EAH); Unit of Infections and Cancer (UNIC), Cancer Epidemiology Research Programme, Institut Català d' Oncologia, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain, CIBER de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain (SdS, YB); Unit of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden (KES); Department of Health Studies, University of Chicago, Chicago, IL (BCHC); Department of Environmental Health Sciences (YZ, TZ) and Department of Biostatistics (TRH), Yale School of Public Health, New Haven, CT; INSERM, Centre for Research in Epidemiology and Population Health (CESP), U1018, Environmental Epidemiology of Cancer Group, Villejuif, France, Univ Paris Sud, UMRS 1018, Villejuif, France (AM, JC, LO); Registry of Hematological Malignancies in Gironde, Bergonié Institute, 33076 Bordeaux, France (AM); Department of Histopathology, Douglass Hanly Moir Pathology, Macquarie Park, Australia, The Australian School of Advanced Medicine, Macquarie University, Sydney, Australia (JJT); Department of Medical Epidemiology and Biostatistics (H-OA) and Department of Oncology and Pathology (BG), Karolinska Institutet, Stockholm, Swed

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jncimonographs/lgu013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155467PMC
August 2014

Latitude gradients for lymphoid neoplasm subtypes in Australia support an association with ultraviolet radiation exposure.

Int J Cancer 2013 Aug 4;133(4):944-51. Epub 2013 Mar 4.

Adult Cancer Program, Lowy Cancer Research Centre, Prince of Wales Clinical School, The University of New South Wales, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.28081DOI Listing
August 2013

No excess risk of follicular lymphoma in kidney transplant and HIV-related immunodeficiency.

Int J Cancer 2010 Dec;127(11):2732-5

UNSW Cancer Research Centre, Prince of Wales Clinical School, University of New South Wales, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.25272DOI Listing
December 2010

Atopy, exposure to pesticides and risk of non-Hodgkin lymphoma.

Int J Cancer 2007 May;120(10):2271-4

National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, 2376 Victoria Street, Darlinghurst, NSW 2010, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.22602DOI Listing
May 2007

Applications of type I antifreeze proteins: studies with model membranes & cryoprotectant properties.

Curr Protein Pept Sci 2006 Dec;7(6):509-22

School of Chemistry, The University of Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
December 2006

Specific infections, infection-related behavior, and risk of non-Hodgkin lymphoma in adults.

Cancer Epidemiol Biomarkers Prev 2006 Jun;15(6):1102-8

National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Level 2/376 Victoria Street, Darlinghurst, New South Wales 2010, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-06-0078DOI Listing
June 2006

WHO non-Hodgkin's lymphoma classification by criterion-based report review followed by targeted pathology review: an effective strategy for epidemiology studies.

Cancer Epidemiol Biomarkers Prev 2005 Sep;14(9):2213-9

Department of Anatomical Pathology, St. Vincent's Hospital, Level 6, Xavier Building, Darlinghurst, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-05-0358DOI Listing
September 2005

Heterocyclic inhibitors of dihydrodipicolinate synthase are not competitive.

Bioorg Med Chem 2005 Mar;13(6):2133-40

School of Chemistry, University of Sydney, Sydney, NSW 2006, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmc.2005.01.001DOI Listing
March 2005

Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression.

Prostate 2004 May;59(3):234-42

Cancer Research Program, Garvan Institute of Medical Research, St. Vincent's Hospital, Darlinghurst, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.10361DOI Listing
May 2004

Prognostic significance of Gleason pattern in patients with Gleason score 7 prostate carcinoma.

Cancer 2003 Dec;98(12):2560-5

Cancer Research Program, Garvan Institute of Medical Research, St. Vincent's Hospital, Darlinghurst, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.11850DOI Listing
December 2003

Inhibitors of lysine biosynthesis as antibacterial agents.

Mini Rev Med Chem 2003 Mar;3(2):115-27

School of Chemistry, The University of Sydney, NSW 2006, Australia.

View Article

Download full-text PDF

Source
March 2003

Pituitary apoplexy in association with lymphocytic hypophysitis.

J Clin Neurosci 2002 Sep;9(5):577-80

Department of Neurosurgery, Concord Hospital, University of Sydney, Sydney CT and MR, Australia.

View Article

Download full-text PDF

Source
September 2002